Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 020833

Expand all

FLOVENT DISKUS 100 (FLUTICASONE PROPIONATE)
0.1MG/INH
Marketing Status: Prescription

Active Ingredient: FLUTICASONE PROPIONATE
Proprietary Name: FLOVENT DISKUS 100
Dosage Form; Route of Administration: POWDER; INHALATION
Strength: 0.1MG/INH
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N020833
Product Number: 002
Approval Date: Sep 29, 2000
Applicant Holder Full Name: GLAXO GROUP LTD ENGLAND DBA GLAXOSMITHKLINE
Marketing Status:  Prescription
Patent and Exclusivity Information

FLOVENT DISKUS 250 (FLUTICASONE PROPIONATE)
0.25MG/INH
Marketing Status: Prescription

Active Ingredient: FLUTICASONE PROPIONATE
Proprietary Name: FLOVENT DISKUS 250
Dosage Form; Route of Administration: POWDER; INHALATION
Strength: 0.25MG/INH
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N020833
Product Number: 003
Approval Date: Sep 29, 2000
Applicant Holder Full Name: GLAXO GROUP LTD ENGLAND DBA GLAXOSMITHKLINE
Marketing Status:  Prescription
Patent and Exclusivity Information

FLOVENT DISKUS 50 (FLUTICASONE PROPIONATE)
0.05MG/INH
Marketing Status: Prescription

Active Ingredient: FLUTICASONE PROPIONATE
Proprietary Name: FLOVENT DISKUS 50
Dosage Form; Route of Administration: POWDER; INHALATION
Strength: 0.05MG/INH
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N020833
Product Number: 001
Approval Date: Sep 29, 2000
Applicant Holder Full Name: GLAXO GROUP LTD ENGLAND DBA GLAXOSMITHKLINE
Marketing Status:  Prescription
Patent and Exclusivity Information